IPO Lysogène

Listing of Lysogène on Euronext

Karen Aiach, Founder and Managing Director, Lysogène, opens the trading day in Paris.

Lysogene is a biotechnology company specializing in the research and development of gene therapies for the treatment of rare neurodegenerative diseases.
The company now has 2 products in development phase for the treatment of Sanfilippo syndrom and gangliosidosis.